Ontology highlight
ABSTRACT: Rationale
Obstructive sleep apnea (OSA) has multiple pathophysiological causes. A low respiratory arousal threshold (ArTh) and a high loop gain (unstable ventilatory control) can contribute to recurrent respiratory events in patients with OSA. Prior studies have shown that donepezil, an acetylcholinesterase inhibitor, might improve OSA, but the mechanism is unknown.Objectives
To determine whether a single dose of donepezil lowers the apnea-hypopnea index by modulating the ArTh or loop gain.Methods
In this randomized, double-blind, crossover trial, 41 subjects with OSA underwent two polysomnograms with ArTh and loop gain evaluated, during which 10 mg of donepezil or placebo was administered.Measurements and main results
Compared with placebo, sleep efficiency
SUBMITTER: Li Y
PROVIDER: S-EPMC5122481 | biostudies-literature | 2016 Nov
REPOSITORIES: biostudies-literature